Microsoft Stock Is Down 30% — Is MSFT Finally a Buying Opportunity?
Microsoft (NASDAQ: MSFT) has shed nearly 30% from its 52-week high of $555.45, trading at $390.96 as of this writing. For a company of this quality, that kind of drawdown tends to get investors’ attention. But does a lower price automatically mean it’s time to buy? We ran MSFT through Ask The Desk to find out what the data actually says.
The Drawdown in Context
At $390.96, MSFT sits approximately 29.6% below its 52-week high — and only about 12% above its annual floor of $349.20. That’s a meaningful compression for one of the largest companies in the world.
To put it in historical perspective: Microsoft has experienced comparable 25-35% drawdowns before. The 2022 rate-hike selloff took the stock from ~$340 to ~$213. The COVID crash in 2020 sliced 30% in weeks. In both cases, the stock not only recovered but went on to make new all-time highs. The question isn’t whether MSFT has survived drawdowns before — it has. The question is whether this one is different, and whether the current price represents genuine value.
Valuation — Cheaper, But Not Cheap
The selloff has brought valuations down from peak levels, but “less expensive” isn’t the same as “cheap”:
- P/E (TTM): 36.3x — compressed from prior highs above 40x, but still elevated relative to the broader market
- Price/FCF: 51.6x — demanding, with FCF per share of approximately $9.63
- EV/EBITDA: 23.6x — modestly below FY2024’s 26.1x, reflecting a partial re-rating
- Price/Sales: ~10.5x — well below the 13.8x seen at FY2024 peak levels
The analyst community remains constructive. Across 17 analysts with targets issued last quarter, the consensus price target sits at $536.88 — implying approximately 37% upside from current levels. One more recent single analyst target of $400 signals near-term caution, but the broader consensus hasn’t capitulated.
The honest read: MSFT is cheaper than it was, but a 51x FCF multiple still leaves limited margin of safety if growth disappoints. This is not a deep value setup — it’s a quality-at-a-discount setup, which is a different trade.
The Fundamental Case — Still One of the Best Businesses on Earth
Whatever the near-term price action says, the underlying business remains exceptional:
- Revenue growth: FY2025 revenue per share of $37.90 vs. $32.99 in FY2024 — approximately 15% growth
- Net margin: 36.1% — one of the highest sustained net margins in large-cap tech
- Operating cash flow margin: 48.3%, generating $18.32 in OCF per share
- Return on equity: 29.6% | ROIC: 21.6% — hallmarks of a high-quality compounder
- Debt/equity: 0.33x | Interest coverage: 53.9x — fortress balance sheet with essentially no financial risk
These are not the numbers of a business in trouble. Revenue is growing double digits, margins are expanding, and the balance sheet gives management enormous flexibility. The bear case on MSFT has never really been about the business — it’s about the price paid for the business.
The AI Capex Question — The Key Risk
The most legitimate concern in the MSFT thesis isn’t valuation — it’s capital allocation. The company is spending aggressively on AI infrastructure:
- Capex/revenue: 22.9% in FY2025, up from 18.1% in FY2024
- This elevated spending is compressing near-term FCF conversion — which directly explains why the Price/FCF of 51.6x looks stretched relative to the P/E of 36.3x
The bull case says this spend is building the infrastructure that will power the next decade of Azure and Copilot revenue. The bear case says the returns on that spend are uncertain, and the market is right to demand a lower multiple until the AI revenue ramp is proven.
This is the central debate in the stock right now. If Azure AI growth re-accelerates and the capex spend proves productive, the 37% upside to analyst targets is well-supported. If AI monetization disappoints or macro conditions deteriorate, there’s more downside from here.
Technical Setup — Not Oversold Yet
The technical picture is mixed — improving at the margins but not yet a clear buy signal:
- RSI (14): 50.0 — dead neutral, neither oversold nor overbought
- MACD: -9.85 (signal: -12.31, histogram: +2.46) — bearish overall, but the histogram turning positive suggests momentum is improving
- Stochastic %K: 79.51 — entering short-term overbought territory on the recent bounce
- OBV trend: Rising — on-balance volume is accumulating despite price weakness, a constructive sign
- Bollinger %B: 55.4% — mid-band, not extended in either direction
- 20-day VWAP: $381.72 — price is trading above this level, a short-term positive
The critical levels to watch:
| Level | Price | Significance |
|---|---|---|
| 52-Week High | $555.45 | Full recovery target |
| 200-day SMA | $445.44 | Major resistance |
| 50-day SMA | $408.27 | First resistance to reclaim |
| Current Price | $390.96 | — |
| 20-day VWAP | $381.72 | Near-term support |
| 52-Week Low | $349.20 | Cycle floor |
The bottom line technically: MSFT needs to reclaim $408 (50-day SMA) to signal a genuine recovery, and ultimately $445 (200-day SMA) to confirm a trend reversal. Until those levels are reclaimed, the path of least resistance remains cautious. The stock is not oversold — there’s no technical urgency to buy the dip today.
Bull vs. Bear — The 12-Month Scenarios
| Scenario | Assumption | Implied Price |
|---|---|---|
| Bear | AI capex disappoints, multiple compresses to 28x P/E | ~$310 |
| Base | Steady growth, re-rate to 32x P/E on improving sentiment | ~$460 |
| Bull | AI revenue accelerates, consensus target achieved | ~$537 |
| Recovery | Full reversion to prior highs | $555+ |
The base case implies roughly 18% upside from current levels. The bull case — which aligns with analyst consensus — implies 37%. The bear case requires a meaningful deterioration in either fundamentals or market sentiment toward tech multiples broadly.
The Verdict — Patient Accumulation, Not Aggressive Buying
Microsoft’s 30% drawdown has brought a world-class business to a more reasonable price. The fundamental quality is undeniable: 36% net margins, 21.6% ROIC, double-digit revenue growth, and a balance sheet that could absorb almost any macro shock.
But the setup favors patience over urgency. The stock is not technically oversold. It remains below both key moving averages. And at 51x FCF, the valuation still requires continued execution to justify. The AI capex overhang won’t resolve in a single quarter.
The smarter approach: watch for MSFT to reclaim the $408 level (50-day SMA) on strong volume — that’s the first technical confirmation that the worst is over. For long-term investors with a 2-3 year horizon, the current price likely looks attractive in hindsight. For traders looking for a near-term catalyst, the setup isn’t quite there yet.
The 37% upside to analyst consensus is real — but so is the patience required to capture it.
This analysis was researched using Ask The Desk, In2Trading’s AI-powered stock analysis platform. Ask The Desk pulls live market data, technical indicators, valuation metrics, and fundamental data to deliver institutional-quality analysis in seconds — built for self-directed investors who want answers, not raw charts.
Financial disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence before making any investment decisions.